This site uses tracking information. Visit our privacy policy. Click to agree to this policy and not see this again.

Ophthalmology and Visual Sciences

Weill-Marchesani Syndrome

12-year-old female referred to the glaucoma clinic for suspected chronic angle closure of the left eye

Weill-Marchesani Syndrome

12-year-old female referred to the glaucoma clinic for suspected chronic angle closure of the left eye
Wisam Najdawi, BS; Sean Rodriguez, MD; Zachary Q. Mortensen, MD, MBA; Andrew E. Pouw, MD; Scott A. Larson, MD
July 10, 2023

INITIAL PRESENTATION

Chief Complaint: Suspected chronic angle closure of the left eye (OS)

History of Present Illness: A 12-year-old female was referred to the Glaucoma service for suspected chronic angle closure OS. Intraocular pressures were measured to be 19 mm Hg in the right eye (OD) and 38 mm Hg OS with concern for a very shallow anterior chamber OS by an outside optometrist. She was started on brimonidine-timolol 0.2-0.5% twice daily (BID) OS prior to evaluation here.

At presentation, she reported difficulty focusing on the board at school, needing to hold things very close to her face to focus, and difficulty noticing people standing beside her.

Past Ocular History:

  • Suspected chronic angle closure, OS>OD
  • High myopia, both eyes (OU)
    • OD: -14.50 -3.25 x115 with best corrected acuity 20/60 at distance
    • OS: -14.50 -4.25 x075 with best corrected acuity 20/50 at distance

Past Medical History:

  • Born full term, pregnancy complicated by maternal alcohol and drug use
  • Congenital mitral valve stenosis s/p mitral valve repair x 1 (6 months old) and replacement x 2 (7 months old, 9 years old)

Medications:

  • Brimonidine-timolol 0.2%/0.5%, 1 drop BID OS
  • Warfarin, 6 mg M/W/F, 5 mg T/Th/S/S

Allergies: No known allergies

Family History: No family history of congenital cataracts, glaucoma, or other eye diseases

Social History: Non-contributory

Review of Systems: Positive for finger stiffness and difficulty making a fist bilaterally. All other systems reviewed and negative.


OCULAR EXAMINATION

  • External Exam
    • Brachydactyly of the hands, prominent interphalangeal joints, and taut skin of the hands bilaterally (Figure 1). Bilateral fingers were stiff with poor fist formation (Video 1).
    • Height: 135.6 cm (percentile: <1%; Figure 2)
  • An external photograph of the patient's hands demonstrating bilateral brachydactyly, prominent interphalangeal joints, and taut skin of the hands.
    Figure 1: An external photograph of the patient's hands demonstrating bilateral brachydactyly, prominent interphalangeal joints, and taut skin of the hands.
    Growth chart of this patient demonstrating height measurements consistently below the 1st percentile.
    Figure 2: Growth chart of this patient demonstrating height measurements consistently below the 1st percentile.
  • Visual Acuity with correction (Snellen)
    • OD: 20/125, pinhole (ph) 20/80
    • OS: 20/125, ph 20/80
  • Pachymetry
    • OD: 562 µm
    • OS: 563 µm
  • Intraocular Pressure (Applanation)
    • OD: 15 mm Hg
    • OS: 18 mm Hg
  • Slit Lamp Exam
    • Cornea
      • OD: Iris-cornea (I-K) touch inferonasally about four clock hours
      • OS: Clear
    • Anterior Chamber
      • OD: Shallow with anteriorly protruding lens and iridopupillary strand
      • OS: Shallow (more so inferonasally) with iridopupillary strand and vitreous protruding inferiorly from behind lens
    • Iris
      • OU: Normal architecture without iris bombe
    • Lens (Figure 3-4):
      • OD: Spherical shape, dislocated superonasally with phacodonesis and loose zonular fibers inferotemporally
      • OS: Spherical shape, protruding through pupil and dislocated superonasally with phacodonesis and missing zonular fibers inferotemporally
  • Slit lamp photographs demonstrating superonasal lens dislocation and loose zonules OD (A) and superonasal lens dislocation OS (B).
    Figure 3: Slit lamp photographs demonstrating superonasal lens dislocation and loose zonules OD (A) and superonasal lens dislocation OS (B).
    Slit lamp photographs demonstrating superonasal lens dislocation OD (A) and OS (B) on retroillumination.
    Figure 4: Slit lamp photographs demonstrating superonasal lens dislocation OD (A) and OS (B) on retroillumination.
  • Gonioscopy
    • OD: B30f3+ in all quadrants, dysgenic appearance, I-K touch temporally
    • OS: A(B)15f3+ in all quadrants, significant iris rise
  • Dilated Fundus Examination (Figure 5)
    • Disc
      • OU: Anomalous appearing disc, no disc hemorrhage
    • Cup-to-Disc Ratio
      • OD: 0.45
      • OS: 0.75
    • Macula
      • OU: Flat
    • Vessels
      • OU: Normal
    • Periphery
      • OU: Normal
  • Fundus photos OD (A) and OS (B).
    Figure 5: Fundus photos OD (A) and OS (B).
  • Axial Eye Length (AEL): 24 mm OU (Normal: 22-25 mm) (1)
  • Optical Coherence Tomography (OCT) of Optic nerve head (Figure 6)
    • OD: Apparent deficit of the superior peripapillary retinal nerve fiber layer thickness (pRNFLT) bundle
    • OS: Apparent deficit of both the superior and inferior pRNFLT bundles
  • Optic nerve head and retinal nerve fiber layer OCT report. Age-normative data is unavailable for patients <18 years old.
    Figure 6: Optic nerve head and retinal nerve fiber layer OCT report. Age-normative data is unavailable for patients <18 years old.
  • Anterior Segment OCT (AS-OCT) (Figure 7)
    • OS: Grossly normal cornea, spherical lens, and very shallow anterior chamber
  • AS-OCT OS demonstrating a hyper-spherical lens with a shallow anterior chamber.
    Figure 7: AS-OCT OS demonstrating a hyper-spherical lens with a shallow anterior chamber.

Differential Diagnosis for a Dislocated Lens


CLINICAL COURSE

Given the clinical findings of bilateral spherophakia with lens dislocation, high myopia without axial elongation, narrow angle glaucoma based on RNFL thinning and disc changes as listed above, short stature, brachydactyly, and joint stiffness as well as the patient’s history of congenital heart disease, the patient was diagnosed with Weill-Marchesani Syndrome. The patient successfully underwent lensectomy with anterior vitrectomy, left eye first followed by the right eye. The patient was left aphakic, as the main concerns at the time were zonular instability and glaucoma progression. The patient and her family will consider a secondary intraocular lens in the future. Intraocular pressures remained normal. The patient was referred for a genetics evaluation given her syndromic features.


DIAGNOSIS: Weill-Marchesani Syndrome


DISCUSSION

Overview

Weill-Marchesani Syndrome (WMS), also known as spherophakia-brachymorphia syndrome or congenital mesodermal dysmorphodystrophy, is a rare connective tissue disorder that typically presents during childhood and is characterized by lens abnormalities (microspherophakia, ectopia lentis, and lenticular myopia), secondary glaucoma, short stature, brachydactyly, joint stiffness, and cardiovascular defects [2-5].

Epidemiology

The prevalence of WMS is estimated to be 1:100,000 in the general population [2,3].

Genetics

WMS can occur via autosomal recessive (AR) inheritance (45%), autosomal dominant (AD) inheritance (39%), or sporadically (16%) [2,3,5,6]. Penetrance is thought to be 100% for both AD and AR forms. Intra- and inter-familial expressivity varies [3]. The clinical manifestations and disease severity of WMS do not differ between AR, AD, or sporadic forms [6].

Four genes encoding extracellular matrix components are implicated in the pathogenesis of WMS. Pathogenic variants of the FBN1 gene are inherited in an AD manner (WMS 2). Pathogenic variants of the ADAMTS10, ADAMTS17, and LTBP2 genes are inherited in an AR manner (WMS 1, WMS 4, and WMS 3, respectively) [2,3].

Pathophysiology

Fibrillin, a glycoprotein encoded by the FBN1 gene, is a component of many connective tissues throughout the body, including blood vessels, ligaments, dermis, and ciliary zonules. In the ciliary zonules, fibrillin serves as a structural scaffold of extensible microfibrils [2,3,5]. The ADAMTS (A Disintegrin and Metalloprotease with Thrombospondin Motifs) gene superfamily codes for several zinc metallopeptidases involved in proteoglycan processing and appears to play a role in fibrillin regulation and biogenesis [2,3]. Latent transforming growth factor beta-binding protein 2, encoded by the LTBP2 gene, is an extracellular matrix protein involved in the formation and longevity of ciliary zonule fibrillin-containing microfibrils [2,3]. Inherited mutations in the aforementioned genes that encode for microfibrils and zinc metallopeptidases, therefore, confer abnormalities in the structure and function of the lens-zonule apparatus.

Disruption of fibrillin or fibrillin-associated proteins results in zonular weakness leading to lens hypermobility and spherophakia [2,3,5,7]. Hypermobile lenses are prone to dislocation and pupillary block [2,3,5,7,8]. Lens dislocation results in an acute decrease in visual acuity due to refractive shift. Pupillary block causes elevations in intraocular pressure that can lead to acute or chronic glaucomatous damage [2,3,7,8]. High myopia occurs as a result of the increased refractive power of the hyper-spherical lens. Of note, it is very unusual for an individual with high myopia to develop angle closure, as myopic eyes are often elongated with a deep anterior chamber [7,9]. In contrast, myopic individuals with WMS typically have a normal AEL and shallow to normal anterior chamber depth due to the mobile, spherical lens shifting the iris anteriorly.

Signs/Symptoms

Ocular manifestations of WMS include microspherophakia with consequent moderate to severe lenticular myopia, lens hypermobility with susceptibility to lens dislocation and pupillary block, and secondary glaucoma. In a review of 111 microspherophakic eyes, Senthil et al. reported a mean refractive error of -13.31±5.12 D [8]. Additionally, Razeghinejad et al. identified increased central corneal thickness as a feature of WMS [10]. Lenticular myopia is often the first ophthalmologic problem recognized with a mean age of presentation of 7.5 years [2,3]. In a review of 128 patients with WMS, Faivre et al. reported an 80% frequency of glaucoma [6].

Musculoskeletal manifestations of WMS include short stature, brachydactyly, progressive joint stiffness, prominent interphalangeal joints, and pseudomuscular build [2,3]. Adult males and females with WMS are expected to achieve a height of 142-169 cm (4.7-5.5 ft.) and 130-157 cm (4.3-5.2 ft.), respectively [3]. Patients with WMS may also present with maxillary hypoplasia. Radiographic findings include short tubular bones, delayed bone age, and broad proximal phalanges [2,3].

Cardiovascular of WMS include patent ductus arteriosus, pulmonary stenosis, aortic stenosis, mitral valve prolapse, thoracic aortic aneurysm, cervical artery dissection, and prolonged QT interval [2,3].

Other manifestations include taut skin with thickened skin folds and mild intellectual disability [2-4].

A notable comparison is that between WMS and Marfan syndrome. Both diseases are the result of disruptions of fibrillin and fibrillin-associated proteins. As such, one might suspect that the manifestations of these disease would be similar. However, being an acromelic dysplasia, WMS has been described as “the opposite of Marfan syndrome” [11,12]. Though both diseases present with cardiovascular abnormalities, high myopia, and ectopia lentis, individuals with Marfan syndrome are typically tall, hypomuscular, hypermobile, and have arachnodactyly [5,12]. The prevalence of Marfan syndrome is estimated to be 1:3,000-5,000, making it far more common than WMS [12]. In a review of 396 cases of congenital ectopia lentis, Fuchs and Rosenberg found that 68.2% were due to Marfan syndrome, while only 0.73% were due to WMS [13]. Additionally, the myopia associated with Marfan syndrome is attributed to axial elongation of the eye rather than increased refractive power of the lens [5].

Diagnosis

There are no consensus clinical diagnostic criteria for WMS to date. The diagnosis should be suspected in individuals with characteristic clinical and radiographic findings and can be established with genetic evaluation.

For individuals with suspected AD WMS, genetic evaluation may include serial single-gene analysis of FBN1 to identify intragenic variants. If the inheritance of the disease is unclear, a multigene panel including FBN1, ADAMTS10, ADAMTS17, and LTBP2 may be ordered to identify the responsible genetic variant. If the presenting phenotype is not readily distinguishable from other inherited connective tissue disorders, comprehensive genomic testing (most commonly exome sequencing) may help clarify the diagnosis [2,3].

Management

Management of WMS focuses on treatment of ophthalmic and systemic manifestations of the disease.

Annual ophthalmic examination is recommended for early detection of ectopic lenses, pupillary block, and secondary glaucoma. Miotic and mydriatic agents should be avoided, as they may induce pupillary block [2,3]. Early lensectomy of the microspherophakic lens may improve visual acuity, prevent pupillary block, improve intraocular pressures, and prevent the development of secondary glaucoma. Management of more severe glaucoma may involve peripheral iridectomy or filtering surgery.

Management of systemic symptoms may include physical therapy to maintain joint mobility and regular cardiac examination to screen for anomalies. Patients should be counseled on the risk of participating in contact sports. Genetic counseling may be offered to patients and at-risk family members.

EPIDEMIOLOGY

  • Prevalence of 1:100,000 in the general population

ETIOLOGY

  • Disruption of fibrillin or fibrillin-associated proteins results in zonular weakness leading to lens hypermobility and spherophakia

SIGNS

  • Microspherophakia
  • High myopia, but normal AEL
  • Lens hypermobility, ectopia lentis
  • Pupillary block
  • Short stature
  • Cardiovascular defects
  • Brachydactyly, joint stiffness, and taut, thickened skin

SYMPTOMS

  • Poor distance vision without corrective lenses
  • Progressive joint stiffness
  • Mild intellectual disability

TREATMENT/MANAGEMENT

  • Annual ophthalmic examination
  • Early lensectomy
  • Avoidance of miotics and mydriatics
  • Referral to a glaucoma specialist for management of severe glaucomatous damage
  • Physical therapy
  • Referral to cardiologist for regular cardiac examinations
References
  1. Bhardwaj V, Rajeshbhai GP. Axial length, anterior chamber depth-a study in different age groups and refractive errors. J Clin Diagn Res 2013;7(10):2211-2212. [PMID 24298478]
  2. Johnson S, Fowler BT, Dryden SC, Prakalapakorn SG, Collinge J. Weill-Marchesani Syndrome. [Online Encyclopedia]. EyeWiki: American Academy of Ophthalmology, 2022. [Accessed on January 3 2023] https://eyewiki.org/Weill-Marchesani_Syndrome.
  3. Marzin P, Cormier-Daire V, Tsilou E. Weill-Marchesani Syndrome. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews((R)). Seattle (WA); 1993.
  4. Guo H, Wu X, Cai K, Qiao Z. Weill-Marchesani syndrome with advanced glaucoma and corneal endothelial dysfunction: a case report and literature review. BMC Ophthalmol 2015;15:3. [PMID 25571963]
  5. Ashworth JL, Kielty CM, McLeod D. Fibrillin and the eye. Br J Ophthalmol 2000;84(11):1312-1317. [PMID 11049961]
  6. Faivre L, Dollfus H, Lyonnet S, Alembik Y, Megarbane A, Samples J, Gorlin RJ, Alswaid A, Feingold J, Le Merrer M, Munnich A, Cormier-Daire V. Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome. Am J Med Genet A 2003;123A(2):204-207. [PMID 14598350]
  7. Alward WLM. Lens-associated Glaucomas. Iowa Glaucoma Curriculum, 2019
  8. Cruickshank FE, Logan NS. Optical 'dampening' of the refractive error to axial length ratio: implications for outcome measures in myopia control studies. Ophthalmic Physiol Opt 2018;38(3):290-297. [PMID 29691929]
  9. Razeghinejad MR, Safavian H. Central corneal thickness in patients with Weill-Marchesani syndrome. Am J Ophthalmol 2006;142(3):507-508. [PMID 16935606]
  10. McKusick VA. The Weill-Marchesani Syndrome. In: McKusick VA, editor. Heritable Disorders of Connective Tissue. 4th ed. St. Louis, MO: CV Mosby Company; 1972; p. 282-291.
  11. Sakai LY, Keene DR, Renard M, De Backer J. FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders. Gene 2016;591(1):279-291. [PMID 27437668]
  12. Fuchs J, Rosenberg T. Congenital ectopia lentis. A Danish national survey. Acta Ophthalmol Scand 1998;76(1):20-26. [PMID 9541430]
Suggested citation format:

Najdawi W, Rodriguez S, Mortensen ZQ, Pouw AE, Larson SA. Weill-Marchesani Syndrome. EyeRounds.org. Posted July 10, 2023; Available from https://EyeRounds.org/cases/344-weill-marchesani-syndrome.htm


last updated: 08/03/2023

Image Permissions:
Creative Commons

Ophthalmic Atlas Images by EyeRounds.org, The University of Iowa are licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.